Clinical trials · Chicago, IL
Hemorrhage clinical trials in Chicago
We’re tracking 20 recruiting hemorrhage studies with a site in or near Chicago — including Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near Chicago
- NCT06836141Recruiting
Biomarkers for memory decline after brain hemorrhage
This study looks for biological signs that might predict memory problems after a brain bleed, which could help doctors provide better care.
Chicago, IllinoisAges 18–80 - NCT06870812Recruiting
Quick removal of brain bleed clot study
This trial tests a rapid procedure to remove a blood clot in the brain after a specific type of stroke. It might help people with a moderate-sized bleed in the front part of the brain if treatment can start within 24 hours.
Chicago, IllinoisAges 18–70 - NCT05488457RecruitingPhase 2
Oxytocin timing and effects during planned C-section
This study looks at how oxytocin (a medicine often used to help with labor and uterine contractions) moves through the body and what it does during a non-emergency C-section. It may help improve how oxytocin is used in the future for safer, more predictable delivery care.
Chicago, IllinoisAges 18–50 - NCT06664775RecruitingPhase 3
Comparing two bleeding-control patches during open surgery
This study tests a special patch called TachoSil against a standard surgical pad (Surgicel) to see which works better for controlling minor oozing during open abdominal, chest, or pelvic surgeries. It may be an option if you are having certain types of surgery and have a small area of mild bleeding that needs help to stop.
Chicago, IllinoisAges 1 month+ - NCT06820177RecruitingPhase 4
Tranexamic acid to reduce bleeding during abortion or miscarriage
This trial is testing if a medicine called tranexamic acid (TXA) can help reduce bleeding during a second-trimester abortion or miscarriage procedure. The goal is to make the procedure safer for patients.
Chicago, IllinoisAges 18 years+ - NCT07362225Recruiting
MPN Progress Registry: Tracking Symptoms and Progression
This observational registry tracks symptoms, treatments, and disease changes over time in people diagnosed with myeloproliferative neoplasms (MPNs). By joining, you help doctors learn more about the condition and possibly contribute to better future care.
Chicago, IllinoisAges 18 years+ - NCT03907046RecruitingPhase 3
Blood thinner study to prevent stroke after brain bleed
This Phase 3 study tests whether a blood thinner (apixaban) can help prevent another stroke and support recovery after you’ve had a brain bleed. You would be assigned to a treatment group, and the study checks safety and whether strokes can be reduced without causing dangerous bleeding.
Chicago, IllinoisAges 18 years+ - NCT06094478Recruiting
Stroke emergency protocol study
This study tests a hospital stroke protocol to quickly evaluate and manage patients with a stroke caused by a clot (AIS), bleeding in the brain (ICH), or bleeding around the brain (SAH). It may help improve emergency care and outcomes.
Chicago, IllinoisAges 18 years+ - NCT07227246RecruitingPhase 3
Testing rFVIIa for bleeding stroke within 2 hours
This trial tests whether a drug called Recombinant Factor VIIa (rFVIIa) can safely help stop bleeding in the brain during a hemorrhagic stroke. The goal is to give the drug as quickly as possible, within 2 hours of stroke onset, to see if it improves outcomes.
Chicago, IllinoisAges 18–80 - NCT06127602Recruiting
Electrical stimulation plus walking for stroke recovery
This study tests whether adding a type of electrical stimulation to leg muscles during walking can improve walking ability for people who are at least 6 months past a stroke. If you have weakness on one side and can walk on a treadmill with some help, you may be able to join.
Chicago, IllinoisAges 18–90 - NCT06742801Recruiting
Onyx liquid embolic for active bleeding outside the brain and heart
This trial tests a liquid material called Onyx that is injected into blood vessels to stop active bleeding in areas like the arms, legs, belly, or chest. It may help people with uncontrolled bleeding that needs to be blocked quickly.
Chicago, IllinoisAges 22 years+ - NCT06725108Recruiting
Hemodynamic monitor for brain injury patients
This trial tests a new monitor that tracks blood flow in patients with severe traumatic brain injury or bleeding in the brain. The device may help doctors better manage care for these critically ill patients.
Chicago, IllinoisAges 18–80 - NCT04916210Recruiting
Study how stroke type affects thinking and recovery
This study looks at what predicts memory and thinking problems after different types of stroke or brain bleeding, and how blood-vessel changes relate to recovery. You may be invited if you recently had a stroke/bleed and can complete a baseline check within 6 weeks.
Chicago, IllinoisAges 18 years+ - NCT04494295Recruiting
Minimally invasive surgery registry for bleeding in the brain
This study records and compares outcomes for people with a specific kind of sudden brain bleeding (intracerebral hemorrhage) using minimally invasive surgery. It may help doctors understand which patients benefit most and improve future care decisions.
Chicago, IllinoisAges 18 years+ - NCT00682695Recruiting
Study genetic and environmental risks for brain bleeding stroke
This study looks at how genes and life factors may contribute to a type of stroke caused by bleeding in the brain. You may be eligible if you’ve had a spontaneous (not caused by injury or infection) brain bleed and can complete consent, interviews, blood pressure checks, and a DNA sample.
Chicago, IllinoisAges 18 years+ - NCT04278404Recruiting
Drug safety study for children already on certain medicines
This study measures how certain medicines move through the body and checks their safety in children. It may help doctors better understand dosing and side effects in kids who are already receiving these treatments, or in some kids who recently tested positive for COVID-19.
Chicago, IllinoisAges birth–20 years - NCT07143019Recruiting
A new device for treating wide-necked brain aneurysms
This trial tests a special device (p48/64 MW HPC) to treat certain brain aneurysms that are wide-necked or have a shape that makes them hard to treat. It might help people with aneurysms that haven't ruptured or that have been treated before and are now coming back.
Chicago, IllinoisAges 18 years+ - NCT06898034Recruiting
Ultrasound after childbirth to predict bleeding risk
This trial uses an ultrasound after you give birth to see if it can help predict heavy bleeding. It aims to find safer ways to monitor and prevent hemorrhage in new mothers.
Evanston, IllinoisAges 17 years+ - NCT06893588Recruiting
NeVa VS for cerebral vasospasm after brain bleed
This trial is for people who have had a brain bleed from a burst aneurysm and then developed tightening of the brain's blood vessels (vasospasm). It studies how well the NeVa VS device works to open up those narrowed vessels.
Evanston, IllinoisAges 22 years+ - NCT06402968Recruiting
Clevidipine for treating high blood pressure after a brain bleed
This trial tests a blood pressure medicine called clevidipine given through an IV to people with a brain bleed (intracerebral hemorrhage). The goal is to see if quickly lowering blood pressure helps prevent more bleeding and improve recovery.
Munster, IndianaAges 18–100
Hear when a new Hemorrhage trial opens near Chicago, IL
We’ll email you when one opens near Chicago, IL — at most once a week, no account needed, unsubscribe anytime.
Hemorrhage trials in other cities
Where these studies are running near Chicago
Institutions with a site for the recruiting hemorrhage studies listed above.
- University of Chicago · 7 studies
- Rush University Medical Center · 5 studies
- Endeavor Health · 3 studies
- University of Illinois · 3 studies
- Northwestern Medicine Central DuPage Hospital · 2 studies
- Advocate Aurora Research Institute
- Advocate Lutheran General Hospital
- Ann & Robert H. Lurie Children's Hospital of Chicago
What taking part in a hemorrhage study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting hemorrhage studies in Illinois.
Common questions
- Are there hemorrhage clinical trials near Chicago?
- Yes. We're currently tracking 20 recruiting hemorrhage studies with a site near Chicago, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a hemorrhage study near Chicago?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Chicago to take part?
- Not necessarily. These studies have a site near Chicago, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a hemorrhage trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New hemorrhage studies open near Chicago regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.